+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 2
Age: 18Years +
All Genders
ID00000236

Buprenorphine Pharmacology Related to Addiction Treatment

Led by National Institute on Drug Abuse (NIDA) · Updated on 2005-08-17

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.

CONDITIONS

Brief Title

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here